Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Point-of-Care (POC) Coagulation Testing Market Size, Value And Growth Trajectory Through 2030#_x000D_
The point-of-care (poc) coagulation testing market size has shown consistent expansion in recent years. Its valuation is projected to increase from $1.25 billion in 2025 to $1.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The development observed in previous periods can be linked to the increasing occurrence of cardiovascular diseases requiring anticoagulation treatment, a greater need for quick coagulation results in operating theatres and intensive care units, the early clinical acceptance of optical and mechanical poc testing systems, the broadening scope of coagulation monitoring within hospital and clinic environments, and enhanced understanding of point-of-care diagnostics for improving treatment efficacy._x000D_
_x000D_
The point-of-care (poc) coagulation testing market is projected to experience consistent expansion over the upcoming years, reaching a valuation of $1.52 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.1%. This anticipated growth during the forecast period is primarily fueled by a growing move towards decentralized and home-based coagulation monitoring, increased use of electrochemical detection technologies, higher volumes of procedures in emergency and trauma care settings, wider availability through retail and direct tender distribution channels, and an intensified focus on reducing processing times and enhancing therapeutic results. Key trends expected over the forecast period encompass the increasing integration of rapid bedside coagulation testing in critical and emergency care, the expanded application of poc coagulation devices for tracking anticoagulation therapy, a rising demand for portable and handheld coagulation analysis instruments, the broader deployment of coagulation testing in home care and outpatient scenarios, and a surging need for real-time clinical decision support facilitated by near-patient testing._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Point-of-Care (POC) Coagulation Testing Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The escalating occurrence of cardiovascular diseases is projected to stimulate the expansion of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is valuable in managing Cardiovascular diseases (CVDs) due to its ability to provide real-time coagulation status updates. This enables prompt decisions on interventions and lowers the risk of bleeding complications post-cardiac surgery. As an illustration, in October 2024, the Centers for Disease Control and Prevention, a US-based public health institute, reported that in 2023, roughly 1 out of every 6 deaths from cardiovascular diseases affected adults younger than 65 years old, and 919,032 people died from cardiovascular disease, representing 1 in every 3 deaths. Thus, the increasing prevalence of cardiovascular diseases is propelling the growth of the point-of-care (POC) coagulation testing market._x000D_
_x000D_
#Point-of-Care (POC) Coagulation Testing Market Segment Analysis And Revenue Potential#_x000D_
The point-of-care (poc) coagulation testing market covered in this report is segmented – _x000D_
_x000D_
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology_x000D_
2) By Distribution Channel: Direct Tenders, Retail_x000D_
3) By End-User: Hospitals, Clinics, Home care_x000D_
_x000D_
Subsegments:_x000D_
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection_x000D_
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection_x000D_
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection_x000D_
_x000D_
#Point-of-Care (POC) Coagulation Testing Market Trends Redefining Industry Growth#_x000D_
Leading companies in the point-of-care (POC) coagulation testing market are prioritizing the innovation of connected POC coagulation solutions through strategic partnerships to secure a competitive advantage. A strategic collaboration is defined as a formal arrangement between two or more parties that agree to work together to achieve specific, predetermined, and mutually beneficial goals. For example, in January 2023, Jana care, a US-based company that develops biomarker assays for its proprietary digital health platform, partnered with Roche Diagnostics, a Switzerland-based company known for developing diagnostic tests, instruments, and digital solutions that enhance healthcare. This collaboration seeks to develop and distribute a point-of-care blood testing platform designed for screening chronic kidney disease and heart failure. This cutting-edge platform will permit patients to conduct blood tests at home, with clinicians reviewing the results remotely._x000D_
_x000D_
#Point-of-Care (POC) Coagulation Testing Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc _x000D_
_x000D_
#View The Full Point-of-Care (POC) Coagulation Testing Market Report:#_x000D_
_x000D_
#Point-of-Care (POC) Coagulation Testing Market Top Region By Revenue And Market Share#_x000D_
North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.